Clinical Trial Update: Liver Cancer HepaSphere Combined With Cryosurgery [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating HepaSphere drug-eluting beads in combination with cryosurgery for liver cancer. Sponsor: Fuda Cancer Hospital, G…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HepaSphere

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED